Analysts forecast that Perrigo Company PLC (NYSE:PRGO) will report earnings of $0.95 per share for the current quarter, Zacks Investment Research reports. Nine analysts have issued estimates for Perrigo’s earnings, with the highest EPS estimate coming in at $1.07 and the lowest estimate coming in at $0.60. Perrigo reported earnings of $1.26 per share in the same quarter last year, which would indicate a negative year over year growth rate of 24.6%. The firm is expected to issue its next earnings results on Tuesday, May 14th.
According to Zacks, analysts expect that Perrigo will report full year earnings of $4.17 per share for the current fiscal year, with EPS estimates ranging from $3.93 to $4.40. For the next fiscal year, analysts anticipate that the company will report earnings of $4.54 per share, with EPS estimates ranging from $4.18 to $5.04. Zacks’ EPS averages are an average based on a survey of analysts that follow Perrigo.
Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Wednesday, February 27th. The company reported $0.97 earnings per share for the quarter, missing analysts’ consensus estimates of $0.98 by ($0.01). Perrigo had a net margin of 2.77% and a return on equity of 10.74%. The company had revenue of $1.20 billion during the quarter, compared to analyst estimates of $1.18 billion. During the same quarter in the previous year, the business posted $1.28 earnings per share. The company’s revenue for the quarter was down 6.5% on a year-over-year basis.
A number of research analysts recently issued reports on PRGO shares. ValuEngine lowered shares of Perrigo from a “hold” rating to a “sell” rating in a report on Thursday, December 20th. Wells Fargo & Co dropped their price objective on shares of Perrigo from $64.00 to $46.00 and set a “market perform” rating for the company in a report on Friday, December 21st. Cantor Fitzgerald set a $107.00 price objective on shares of Perrigo and gave the company a “buy prgo” rating in a report on Thursday, December 20th. Morgan Stanley set a $67.00 price objective on shares of Perrigo and gave the company a “hold” rating in a report on Sunday, December 23rd. Finally, Leerink Swann dropped their price objective on shares of Perrigo from $70.00 to $56.00 in a report on Monday, December 24th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $74.33.
NYSE PRGO traded down $1.04 during trading hours on Thursday, reaching $48.82. The company’s stock had a trading volume of 1,278,452 shares, compared to its average volume of 1,373,728. The firm has a market cap of $6.77 billion, a PE ratio of 10.73, a price-to-earnings-growth ratio of 2.58 and a beta of 1.31. Perrigo has a 52 week low of $36.28 and a 52 week high of $82.95. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.89 and a quick ratio of 1.32.
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Friday, March 1st were issued a dividend of $0.19 per share. The ex-dividend date was Thursday, February 28th. This represents a $0.76 annualized dividend and a yield of 1.56%. Perrigo’s payout ratio is 16.70%.
Institutional investors have recently added to or reduced their stakes in the business. Atlas Capital Advisors LLC bought a new stake in shares of Perrigo in the 4th quarter valued at $26,000. Moody National Bank Trust Division bought a new stake in shares of Perrigo in the 1st quarter valued at $32,000. Oregon Public Employees Retirement Fund increased its stake in shares of Perrigo by 3,574.9% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,430,805 shares of the company’s stock valued at $37,000 after acquiring an additional 1,391,870 shares in the last quarter. Advisor Group Inc. increased its stake in shares of Perrigo by 822.2% in the 4th quarter. Advisor Group Inc. now owns 1,079 shares of the company’s stock valued at $41,000 after acquiring an additional 962 shares in the last quarter. Finally, Covington Capital Management bought a new stake in shares of Perrigo in the 4th quarter valued at $46,000. Hedge funds and other institutional investors own 85.29% of the company’s stock.
Perrigo Company Profile
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Featured Story: Is the Dow Jones Industrial Average (DJIA) still relevant?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.